Hypothesis
VCP, a complement inhibitor that protects nerve tissue in brain and spinal cord injury models, would protect the rat retina from light-induced degeneration.
What failed
In light-damaged retinas, VCP did not reduce photoreceptor loss, retinal stress or inflammation compared with saline. Injected VCP spread through the retina but was cleared within 1 to 3 hours.
Broken assumption
A single eye injection of a complement inhibitor stays in the retina long enough to protect it.
Why
VCP did not stay in the retina long enough to act, so a slow-release delivery method is needed before the idea can be properly tested.
From the published paper: Fernando et al. PLoS ONE, 2018. ↗CC BY